Calendar

pharmadog

Week of Feb 23, 2026

Feb 25, 2026approval185d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval185d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval185d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval185d agoZIOPTAN (TAFLUPROST) — FDA approvaltafluprost

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →tafluprost →fda approvals ↗

Feb 25, 2026approval185d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Feb 25, 2026approval185d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval185d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalBioXcel Therapeutics, Inc.

Sponsor: DR REDDYS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval185d agoHYDROCORTISONE — FDA approvalET-800

Sponsor: APPCO. Form: TABLET. Route: ORAL

full page →ET-800 →fda approvals ↗

Feb 25, 2026approval185d agoCETIRIZINE HYDROCHLORIDE — FDA approvalCETIRIZINE HYDROCHLORIDE

Sponsor: RUBICON RESEARCH. Form: SOLUTION. Route: ORAL

full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗

Feb 25, 2026approval185d agoBUPROPION HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval185d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval185d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval185d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

Sponsor: BEIJING YILING. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval185d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval185d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 25, 2026approval185d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval185d agoDESMODA (DESMOPRESSIN ACETATE) — FDA approvaldesmopressin acetate

Sponsor: ETON. Form: SOLUTION. Route: ORAL

full page →desmopressin acetate →fda approvals ↗

Feb 25, 2026approval185d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Feb 25, 2026grant185d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Advancing Cardiovascular Health Among Adolescents with Intellectual Disabilit...

NR grant. $169,189. PI: Patricia Marie West

full page →nih reporter ↗

Feb 25, 2026grant185d agoUNIVERSITY OF COLORADO DENVER — Understanding the contributions of MAIT cells in colitisUniversity of Colorado Denver

AI grant. $429,000. PI: Li Yen Loh

full page →nih reporter ↗

Feb 25, 2026grant185d agoKEYSTONE SYMPOSIA — B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments

AI grant. $14,000. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Feb 25, 2026grant185d agoKEYSTONE SYMPOSIA — B Cells and Plasma Cells: Fundamental and Translational Biology

AI grant. $15,500. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Feb 25, 2026grant185d agoFLORIDA STATE UNIVERSITY — Multi-level factors influencing maternal and infant health outcomes

HD grant. $540,915. PI: Patricia Ann Homan

full page →nih reporter ↗

Feb 25, 2026grant185d agoMAYO CLINIC JACKSONVILLE — Role of meningeal lymphatic drainage in CSF1R-related leukoencephalopathyMayo Clinic

NS grant. $50,114. PI: Guadalupe Sanchez

full page →nih reporter ↗

Feb 26, 2026approval184d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval184d agoDAPSONE — FDA approvalDAPSONE

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →DAPSONE →fda approvals ↗

Feb 26, 2026approval184d agoJASCAYD (NERANDOMILAST) — FDA approvalnerandomilast

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →nerandomilast →fda approvals ↗

Feb 26, 2026approval184d agoVYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approvalARGENX SE

Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval184d agoBUMETANIDE — FDA approvalEdenbridge Pharmaceuticals LLC

Sponsor: ANTHEA PHARMA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 26, 2026approval184d agoPHYTONADIONE — FDA approvalPHYTONADIONE

Sponsor: SINOTHERAPEUTICS INC. Form: TABLET. Route: ORAL

full page →PHYTONADIONE →fda approvals ↗

Feb 26, 2026approval184d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: TARO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval184d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: TARO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval184d agoHERNEXEOS (ZONGERTINIB) — FDA approvalzongertinib

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →zongertinib →fda approvals ↗

Feb 26, 2026approval184d agoRIZAFILM (RIZATRIPTAN BENZOATE) — FDA approvalNAL Pharmaceuticals Ltd

Sponsor: GENSCO. Form: FILM. Route: ORAL

full page →fda approvals ↗

Feb 26, 2026approval184d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalLong Grove Pharmaceuticals LLC

Sponsor: LONG GROVE PHARMS. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 26, 2026approval184d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

full page →ensartinib hydrochloride →fda approvals ↗

Feb 26, 2026approval184d agoPHYTONADIONE — FDA approvalPHYTONADIONE

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Feb 26, 2026approval184d agoIVERMECTIN — FDA approvalIVERMECTIN

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →IVERMECTIN →fda approvals ↗

Feb 26, 2026grant184d agoBETH ISRAEL DEACONESS MEDICAL CENTER — THWART-TB : Testing Health Workers At Risk to advance our understanding of TB...

AI grant. $111,645. PI: Ruvandhi Nathavitharana

full page →nih reporter ↗

Feb 26, 2026grant184d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Uncovering Morphogenetic Modularity with Data Science

GM grant. $400,881. PI: Tomer Stern

full page →nih reporter ↗

Feb 26, 2026grant184d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Multi-glycomic characterization of cell membrane and the role of glycans in p...

GM grant. $402,051. PI: CARLITO B LEBRILLA

full page →nih reporter ↗

Feb 27, 2026approval183d agoPREZCOBIX (DARUNAVIR AND COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

Sponsor: JANSSEN PRODS. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗

Feb 27, 2026approval183d agoSILIQ (BRODALUMAB) — FDA approvalBausch Health US LLC

Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 27, 2026approval183d agoZEPZELCA (LURBINECTEDIN) — FDA approvallurbinectedin

Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS

full page →lurbinectedin →fda approvals ↗

Feb 27, 2026approval183d agoPALYNZIQ (PEGVALIASE-PQPZ) — FDA approvalBIOMARIN PHARMACEUTICAL INC

Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 27, 2026approval183d agoCALCITRIOL — FDA approvalSun Pharmaceutical Industries Ltd

Sponsor: HUMANWELL PURACAP. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoPREZCOBIX (COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

Sponsor: ALMATICA. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →duloxetine hydrochloride DR →fda approvals ↗

Feb 27, 2026approval183d agoIZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approvalavacincaptad pegol sodium

Sponsor: ASTELLAS. Form: SOLUTION. Route: INTRAVITREAL

full page →avacincaptad pegol sodium →fda approvals ↗

← prev

page 1 of 40

Week of Feb 23, 2026